It is FDA-approved to improve blood sugar in adults with type 2 diabetes and to reduce certain cardiovascular and kidney-related risks in specific adults with type 2 diabetes
The jump from 5mg to 10mg, on the other hand, is enormous, a leap from 16% to 21.4% average body weight reduction
, Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial, Nat
Conflating them under a single search result misleads the patient who specifically wants to understand the branded Zepbound pathway before speaking with a provider
16 Based on these data, it is reasonable to decrease background prandial insulin doses by 50%, or even hold the prandial insulin altogether in patients with good glucose control or a history of hypoglycemia when starting a GLP-1 RA
ontarioangel245 1y ago On Apr 23, 2025 ontarioangel245 successfully applied the code "KAILY100" via DontPayFull extension on tryeden.com